Atrial flutter-related health care use and costs: An analysis of a nationally representative administrative claims database in the United States

被引:0
|
作者
Deshmukh, Abhishek [1 ]
Iglesias, Maximiliano [2 ]
Khanna, Rahul [3 ,4 ]
Beaulieu, Tara [3 ]
机构
[1] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA
[2] Johnson & Johnson Med Devices, Franchise Hlth Econ & Market Access, Irvine, CA USA
[3] Johnson & Johnson, MedTech Epidemiol & Real World Data Sci, New Brunswick, NJ USA
[4] Johnson & Johnson, MedTech Epidemiol & Real World Data Sci, 410 George St, New Brunswick, NJ 08901 USA
来源
HEART RHYTHM O2 | 2023年 / 4卷 / 06期
关键词
Arrhythmia; Atrial flutter; Cost burden; Health care use burden; United States; FIBRILLATION; PREVALENCE; MORTALITY; ABLATION; BURDEN;
D O I
10.1016/j.hroo.2023.04.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Atrial flutter (AFL) is a common arrhythmia associ-ated with significant morbidity, yet the incremental burden of this condition has not been well documented. OBJECTIVE Using real-world data, we sought to evaluate the healthcare use and cost burden of incident AFL in the United States METHODS From 2017 to 2020, persons with an incident diagnosis of AFL were identified through Optum Clinformatics, a nationally representative administrative claims database of commercially insured individuals in the United States. We constructed 2 cohorts (AFL patient; non-AFL comparator) and used a matching weights method to balance covariates between cohorts. Using logistic regression and general linear models, 12-month all-cause and car-diovascular (CV)-related health care use (inpatient, outpatient, emergency room [ER] visits, and other) as well as medical expendi-tures were compared between the matched cohorts. RESULTS The matching weight sample sizes were 13,270 for AFL and 13,683 for the non-AFL cohorts. In the AFL cohort, w71% were at least 70 years of age, 62% identified as male, and 78% iden-tified as White. The AFL cohort had significantly higher health care use, including all-cause (relative risk [RR] 1.14; 95% confidence in-terval [CI] 1.11-1.18) and CV-related ER visits (RR 1.60; 95% CI 1.52-1.70) compared with the non-AFL cohort. Mean total health care costs (per patient annually) were almost $21,783 (95% CI $18,967-$24,599) higher among patients with AFL compared to those without AFL ($71,201 vs $49,418, respectively; P ,.001). CONCLUSION Amidst the backdrop of an aging population, find-ings from this study draw attention to the importance of timely and adequate treatment of AFL.
引用
收藏
页码:367 / 373
页数:7
相关论文
共 50 条
  • [41] DIRECT HEALTH CARE COSTS ASSOCIATED WITH MYASTHENIA GRAVIS (MG) IN HUNGARY: A CLAIMS DATABASE ANALYSIS
    Nagy, B.
    Jesko, J.
    Rozsa, C.
    Gal, K.
    VALUE IN HEALTH, 2024, 27 (12) : S128 - S128
  • [42] Comorbidity Type and Health Care Costs in Type 2 Diabetes: A Retrospective Claims Database Analysis
    Lin, Pei-Jung
    Pope, Elle
    Zhou, Fang Liz
    DIABETES THERAPY, 2018, 9 (05) : 1907 - 1918
  • [43] USE OF A SALINE-COUPLED BIPOLAR SEALER IN OPEN LIVER RESECTIONS FOR HEPATIC MALIGNANCIES: MEDICAL RESOURCE USE AND COSTS FROM A NATIONALLY-REPRESENTATIVE CLAIMS DATABASE
    Nichols, C. I.
    Vose, J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S533 - S534
  • [44] The cost of an itch: A nationally representative retrospective cohort study of pruritus-associated health care expenditure in the United States
    Tripathi, Raghav
    Knusel, Konrad D.
    Ezaldein, Harib H.
    Bordeaux, Jeremy S.
    Scott, Jeffrey F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (03) : 810 - +
  • [45] The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey
    Ganz, Michael L.
    Sugarman, Rebecca
    Wang, Rosa
    Hansen, Brian Bekker
    Hakan-Bloch, Jonas
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (05) : 1032 - 1041
  • [46] Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States
    Ellis, Matthew S.
    Buttram, Mance E.
    Forber, Alyssa
    Black, Joshua C.
    JOURNAL OF PSYCHOACTIVE DRUGS, 2024, 56 (03) : 333 - 341
  • [47] Health Care Administrative Costs in the United States and Canada, 2017 (vol 172, pg 134, 2020)
    Himmelstein, D. U.
    Campbell, T.
    Woolhandler, S.
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (05) : 415 - 415
  • [48] A RETROSPECTIVE CLAIMS ANALYSIS CHARACTERIZING HEALTH CARE RESOURCE USE AMONG PATIENTS WITH FRIEDREICH ATAXIA IN THE UNITED STATES
    Qian, C.
    Lynch, D.
    Powell, L.
    Salvucci, A.
    Vasco, G.
    Johnston, K. M.
    Tomazos, I
    VALUE IN HEALTH, 2023, 26 (06) : S385 - S385
  • [49] Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States
    Buttram, Mance
    Ellis, Matthew
    Black, Joshua
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [50] HEALTH CARE RESOURCE USE AND COSTS OF HEMOPHILIA B (HB) IN FRENCH ADULT PATIENTS IN 2022: A NATIONWIDE CLAIMS DATABASE ANALYSIS
    Frenzel, L.
    Cahoreau, V
    Giraud, N.
    Delienne, S.
    Fagnani, F.
    Bouee, S.
    Cottin, J.
    Bureau, I
    Rudant, J.
    Reynaud, A.
    Fahfouhi, Y.
    Martin, L.
    Beillat, M.
    Kachaner, I
    Lilliu, H.
    Lebreton, A.
    VALUE IN HEALTH, 2024, 27 (12) : S84 - S84